SLC5A2 and polycystic ovary syndrome: In our present study, lowering fat mass by SGLT2 inhibition failed to ameliorate IR [14], mitochondrial dysfunction, and oxidative stress in PCOS, but it increased the relative frequency of small adipocytes in the visceral WAT.